Encision Inc   (ECIA)
Other Ticker:  
Price: $0.4400 $0.01 1.429%
Day's High: $0.44 Week Perf: -12 %
Day's Low: $ 0.37 30 Day Perf: 2.33 %
Volume (M): 11 52 Wk High: $ 0.70
Volume (M$): $ 5 52 Wk Avg: $0.43
Open: $0.38 52 Wk Low: $0.25

 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees -
 Revenues (TTM) (Millions $) 7
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Encision Inc
Encision Inc is a medical device company that develops, manufactures, and markets innovative surgical instruments for minimally invasive surgery. They specialize in the design and production of advanced energy devices used in open and laparoscopic surgical procedures. Encision's products enable surgeons to perform surgeries with increased precision, safety, and effectiveness while minimizing the risk of injury to surrounding tissue. The company is committed to improving patient outcomes and reducing healthcare costs through their cutting-edge surgical technologies.

   Company Address: 6797 Winchester Circle Boulder 80301 CO
   Company Phone Number: 444-2600   Stock Exchange / Ticker: ECIA


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Encision Inc

2. Identifying the Challenges and Opportunities Ahead for Encision Inc in the Medical Equipment & Supplies Industry

Encision Inc, a Medical Equipment & Supplies company, reported mixed results for the third quarter of 2024. While the company achieved zero gain per share, which is an improvement from the previous year's loss of $0.02 per share, the revenue declined by 6.083% to $1.58 million compared to $1.68 million in the same period last year. Sequentially, the revenue deteriorated further by 13.405% from $1.83 million in the previous reporting period.
In contrast to Encision Inc's performance, the Medical Equipment & Supplies industry as a whole recorded a positive top-line growth of 5.58% during the third quarter of 2024 compared to the same period in 2023. This suggests that Encision Inc's results may be out of sync with the broader industry trends.

Encision Inc

Encision Inc: Achieving Stellar Financial Success with Unwavering Balance in Elevation

Encision Inc Breaks Even, Revenue and Demand on the Rise
Encision Inc, a leading Medical Equipment & Supplies company, has reported impressive financial results for the second quarter of 2024. With a break-even point of $0.00 per share, compared to the same period last year, and an increase in revenue by 7.16% to $1.83 million, Encision Inc is showing signs of substantial growth and profitability.
The company's ability to reach break-even amidst the challenging economic climate is a testament to its strong management and strategic decisions. Despite the economic uncertainties, Encision Inc has successfully maintained its financial stability and even improved its performance compared to the previous year.

Encision Inc

Encision Inc faces challenging times as fiscal year comes to a close on June 30, 2023

Encision Inc, a company specializing in medical devices and equipment, has reported its fiscal first-quarter results for 2024. While the company achieved a break-even of $0.00 per share, the figure remained the same as the previous year but declined from $0.02 per share in the preceding reporting period. This indicates that Encision has been able to maintain its financial stability despite the challenging market conditions.
However, the company experienced a decline in revenue during the fiscal first quarter of 2024. The revenue crumbled by -23.254% to $1.65 million compared to $2.15 million in the same reporting period a year ago. Additionally, the revenue deteriorated by -8.44% from $1.81 million in the previous reporting period. This decline in revenue could be attributed to various factors, including changes in customer demand, market competition, and the impact of the ongoing economic uncertainties.

Encision Inc

Encision Inc. Triumphs in Q4 2023 Earnings Season with a Remarkable Revenue Surge of 12.645%!

Date: [Date]
Encision Inc, the Medical Equipment & Supplies company, has recently released its financial results for the fourth quarter of the 2023 earnings season. The company showcased positive indicators, with major improvements seen in earnings per share, revenue growth, and reduced net loss. However, Encision Inc's shares have seen a decline, affecting its year-to-date performance but still remaining above its 52-week low.
Earnings Per Share (EPS) and Profitability:
Encision Inc achieved a significant turnaround in profitability during the fourth quarter of 2023 earnings season. The company reported earnings per share of $0.02, reflecting a positive shift from the $-0.03 loss per share registered in the same period the previous year. Moreover, Encision Inc saw improved performance from the preceding reporting period, where EPS was -$0.02 per share.


Encision Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com